## MAS: Masco Corporation - XLI: Industrials

### Executive Summary

No thesis match: MRS_20 -4.0% below STRENGTH zone (4.0-10.0%); PEG 1.66 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-6.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($57.93)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 6
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Masco Corporation Announces Management Change in Decorative Architectural Products Segment**
- Source: TradingView | 20251208T211516 | Neutral | Relevance: 99%
-  Masco Corporation announced a management change in its Decorative Architectural Products segment. Imran Ahmad, Group President, will conclude his service on December 31, 2025, due to the elimination of his position. Jon Nudi, President & CEO, will take over oversight of the segment.

**2. Barclays Downgrades Masco (MAS): Price Target Lowered to $71 | M**
- Source: GuruFocus | 20251208T144043 | Neutral | Relevance: 99%
-  Barclays analyst Matthew Bouley downgraded Masco (MAS) from Overweight to Equal-Weight, lowering the price target from $76.00 to $71.00 on December 8, 2025. Despite the downgrade, Wall Street analysts project an average target price for Masco Corp of $73.97, implying a 17.04% upside from its current price of $63.20, with a consensus "Hold" rating. GuruFocus estimates Masco's fair value (GF Value) at $70.77, also indicating potential upside.

**3. Masco announces new executive committee to drive growth strategy**
- Source: Investing.com | 20251208T213939 | Neutral | Relevance: 98%
-  Masco Corporation (NYSE:MAS) has unveiled a new Executive Committee structure, effective January 1, 2026, aimed at accelerating its growth strategy. This will be the first time the company combines corporate leadership with presidents of key business units on its executive committee. The 10-member committee, led by President and CEO Jon Nudi, includes new appointments and expanded roles, such as Jai Shah becoming Group President of Plumbing & Wellness and Jen Stone joining as VP and CHRO.

**4. Barclays downgrades Masco stock to Equalweight on tariff concerns**
- Source: Investing.com | 20251208T101144 | Neutral | Relevance: 98%
-  Barclays downgraded Masco (NYSE:MAS) stock from Overweight to Equalweight and lowered its price target to $71.00 from $76.00 due to concerns over potential price-cost headwinds related to Section 232 tariffs. The bank noted that Masco's valuation premium is at near all-time highs despite its quality business model. Masco's recent Q3 2025 earnings also missed expectations, with EPS of $0.97 against an anticipated $1.03 and revenue of $1.92 billion, short by $30 million.

**5. WINTON GROUP Ltd Has $3.70 Million Position in Builders FirstSource, Inc. $BLDR**
- Source: MarketBeat | 20251209T140731 | Neutral | Relevance: 62%
-  WINTON GROUP Ltd significantly increased its stake in Builders FirstSource, Inc. (NYSE:BLDR) by 203.6% in Q2, acquiring 31,674 shares valued at $3.70 million. Despite this, major institutional investors hold much larger positions, with institutional ownership nearing 95.53%. Builders FirstSource recently beat earnings estimates with an EPS of $1.88 and revenue of $3.94 billion, though revenue was down 6.9% year-over-year.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | Barclays | $71 | $76 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | Barclays | down | Equal-Weight |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.6% (-2.5%)
- Blackrock Inc.: 7.7% (-0.1%)
- JPMORGAN CHASE & CO: 4.9% (+164.5%)
- State Street Corpora: 4.9% (+3.8%)
- Harris Associates L.: 3.6% (+1.3%)

### Key Risks

1. Long-term trend broken: trading 8.8% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- New product launch cycle could drive revenue acceleration.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.66 elevated, pricing in significant growth expectations. Forward P/E 14.5x stretched relative to 7% growth. Quality metrics strong (ROE 56%, ROA 15%). Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $12.8B |
| Beta | 1.27 |
| 52W Range | $56.55 - $82.18 |
| Short Interest | 4.3% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.66 |
| Forward P/E | 14.5 |
| Current P/E | 15.5 |
| YoY Growth | 7.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 2.0% to -4.0% (-6.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.0pp (needs >4.0% for momentum thesis). Below SMA200 (0.91x), long-term trend not supportive.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.02% (CS: 26) | Weak |
| RSI_14 | 38.3 | Neutral |
| MACD Histogram | 0.17 | Bullish |
| vs SMA20 | 0.981x | Below |
| vs SMA50 | 0.938x | Below |
| vs SMA200 | 0.912x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $61.11
- **Stop Loss:** $57.93 (5.2% risk)
- **Target:** $64.29 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 157
- **Position Value:** $9,594.27
- **Portfolio %:** 9.59%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite. VIX remains in the mid-range, breadth is moderate, and yield curve is flat but not invertedâ€”indicating standard late-cycle conditions. Upbeat earnings and positive tech momentum are offset by cautious guidance in consumer sectors, suggesting selective positioning is favored.*

### Earnings

**Next:** 2026-02-17 (Est: $0.79)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.03 | $0.97 | -5.7% |
| 2025Q2 | $1.08 | $1.30 | +20.7% |
| 2025Q1 | $0.91 | $0.87 | -4.8% |
| 2024Q4 | $0.87 | $0.89 | +1.9% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*